Emerald Health: Q4 ’18

$17.00

Included in this report:
• Welcome/Contact
• Cannin Tools
• Market & Industry Update
• Fundamental Analysis (Emerald Health)
• Branding
• Medical Research
• Cannabis Terminology
• Hemp Infographic
• Industry Terminology

About Emerald Health

Primary: Production and sales of cannabis in Canada. Later, broader markets, such as Europe. Emerald is science focused, is developing proprietary genetics, has PhD scientists and big-Pharma vets in senior management. Management is interested in the economic potential of CBD.

Secondary: Through the University of British Columbia, it is studying treatments of neurodegenerative and neuroinflammatory diseases, as well as metabolic and other diseases. The first clinical study in humans is planned for late this year. 

Last Updated 12/7/18

Category: